Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 4, 2008

Karo Bio and Zydus Cadila Enter Inflammatory Disease Partnership

  • Karo Bio and Zydus Cadila are working together to discover and develop selective glucocorticoid receptor modulators for the treatment of inflammatory diseases.

    Under the three-year research collaboration Karo Bio will utilize its expertise in nuclear receptor drug discovery including structural biology, drug design, and compound characterization. Zydus Cadila will initiate a focused drug discovery and development program, undertaking preclinical studies, IND application filing, and clinical trials.

    Both parties will equally share the costs and and rewards from this partnership.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »